Blueprint Medicines Corp

CIK 1597264 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Blueprint Medicines Corp.

Recent SEC filings

FiledFormAccession number
Aug 14, 2025SCHEDULE 13G/A0000080255-25-000589
Aug 14, 2025SCHEDULE 13G0000902664-25-003642
Aug 14, 2025SCHEDULE 13G/A0000902664-25-003585
Jul 29, 202515-12G0001193125-25-166915
Jul 24, 2025EFFECT9999999995-25-002337
Jul 21, 202540001104659-25-069379
Jul 21, 202540001104659-25-069381
Jul 21, 202540001104659-25-069388
Jul 21, 202540001104659-25-069383
Jul 21, 202540001104659-25-069394
Jul 21, 202540001104659-25-069392
Jul 21, 202540001104659-25-069378
Jul 21, 202540001104659-25-069393
Jul 21, 202540001104659-25-069382
Jul 21, 202540001104659-25-069384
Jul 21, 202540001104659-25-069377
Jul 21, 202540001104659-25-069385
Jul 21, 202540001104659-25-069391
Jul 21, 202540001104659-25-069390
Jul 21, 202540001104659-25-069387
Jul 21, 2025SCHEDULE 13G0000902664-25-003076
Jul 21, 202540001104659-25-069386
Jul 21, 202540001104659-25-069396
Jul 21, 202540001104659-25-069395
Jul 18, 20258-K0001193125-25-160804